Prime Medicine
(NASDAQ) PRME
Prime Medicine Financials at a Glance
Market Cap
$610.27M
Revenue (TTM)
$4.63M
Net Income (TTM)
$201.14M
EPS (TTM)
$-1.37
P/E Ratio
-2.46
Dividend
$0.00
Beta (Volatility)
1.92 (High)
Dividend
$0.00
Beta (Volatility)
1.92 (High)
Price
$3.10
Volume
54,561
Open
$3.33
Price
$3.10
Volume
54,561
Open
$3.33
Previous Close
$3.38
Daily Range
$3.10 - $3.41
52-Week Range
$1.11 - $6.94
Dividend
$0.00
Beta (Volatility)
1.92 (High)
Price
$3.10
Volume
54,561
Open
$3.33
Previous Close
$3.38
Daily Range
$3.10 - $3.41
52-Week Range
$1.11 - $6.94
PRME News
PRME: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Prime Medicine
Industry
Biotechnology
Sector
Health CareEmployees
146
CEO
Allan Jacob Reine, MD
Website
www.primemedicine.comHeadquarters
Cambridge, MA 02139, US
PRME Financials
Key Financial Metrics (TTM)
Gross Margin
-58%
Operating Margin
-45%
Net Income Margin
-43%
Return on Equity
-147%
Return on Capital
-68%
Return on Assets
-59%
Earnings Yield
-40.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$610.27M
Shares Outstanding
180.55M
Volume
54.56K
Short Interest
0.00%
Avg. Volume
2.98M
Financials (TTM)
Gross Profit
$2.69M
Operating Income
$208.35M
EBITDA
$195.76M
Operating Cash Flow
$162.56M
Capital Expenditure
$4.53M
Free Cash Flow
$167.09M
Cash & ST Invst.
$177.68M
Total Debt
$116.43M
Prime Medicine Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$838.00K
-61.6%
Gross Profit
$39.37M
+1703.5%
Gross Margin
46.98%
N/A
Market Cap
$610.27M
N/A
Market Cap/Employee
$2.85M
N/A
Employees
214
N/A
Net Income
$46.08M
-9.0%
EBITDA
$44.85M
-5.5%
Quarterly Fundamentals
Net Cash
$61.25M
-59.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$108.29M
+191.3%
Short Term Debt
$8.14M
+125.2%
Return on Assets
-58.69%
N/A
Return on Invested Capital
-68.25%
N/A
Free Cash Flow
$37.55M
-359.8%
Operating Cash Flow
$37.26M
-329.3%